# Tripeptide/Hexapeptide Topical and Hybrid Laser Treatment for Acne Scarring

> **NCT04606134** · NA · COMPLETED · sponsor: **University of Rochester** · enrollment: 10 (actual)

## Conditions studied

- Acne Scars - Mixed Atrophic and Hypertrophic

## Interventions

- **DEVICE:** Hybrid fractional laser
- **OTHER:** Alastin Regenerating Skin Nectar with TriHex Technology
- **OTHER:** Cetaphil face cream

## Key facts

- **NCT ID:** NCT04606134
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-13
- **Primary completion:** 2021-06-18
- **Final completion:** 2021-06-18
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04606134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04606134, "Tripeptide/Hexapeptide Topical and Hybrid Laser Treatment for Acne Scarring". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04606134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*